BIOMAT Database Logo BIOMAT Database Logo

Plasma estradiol levels and antidepressant effects of omega-3 fatty acids in pregnant women. 2020

Daisuke Nishi, and Kuan-Pin Su, and Kentaro Usuda, and Jane Pei-Chen Chang, and Kei Hamazaki, and Tamaki Ishima, and Yo Sano, and Hiroe Ito, and Keiich Isaka, and Yoshiyuki Tachibana, and Shinji Tanigaki, and Tomo Suzuki, and Kenji Hashimoto, and Yutaka J Matsuoka
Department of Obstetrics and Gynecology, Tokyo Medical University, Tokyo, Japan; Department of Mental Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Mental Health Policy, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan. Electronic address: d-nishi@umin.ac.jp.

Omega-3 polyunsaturated fatty acids (PUFAs) reduce depressive symptoms through an anti-inflammatory effect, and injection of both omega-3 PUFAs and estradiol (E2) induces antidepressant-like effects in rats by regulating the expression of inflammatory cytokines. The aims of this study were to examine the association of increased E2 during pregnancy with depressive symptoms and with inflammatory cytokines in women who were and were not supplemented with omega-3 PUFAs. Pregnant women with Edinburgh Postnatal Depression Scale scores ≥9 were recruited at 12-24 weeks of gestation. The participants were randomly assigned to receive 1800 mg omega-3 fatty acids (containing 1206 mg eicosapentaenoic acid [EPA]) or placebo for 12 weeks. E2, omega-3 PUFAs, high-sensitivity C-reactive protein, interleukin-6, and adiponectin were measured at baseline and at the 12-week follow-up. Multivariable regression analyses were conducted to examine the association of the changes of E2 and omega-3 PUFAs with the changes in depressive symptoms and with the changes of inflammatory cytokines at follow-up by intervention group. Of the 108 participants in the trial, 100 (92.6%) completed the follow-up assessment including blood sampling. Multivariable regression analyses revealed that the increase of EPA and E2 was significantly associated with a decrease in depressive symptoms among the participants assigned to the omega-3 group, but not among those assigned to the placebo group. Neither E2 nor any PUFAs were associated with a change in inflammatory cytokines. Supplementation with EPA and increased levels of E2 during pregnancy might function together to alleviate antenatal depression through a mechanism other than anti-inflammation.

UI MeSH Term Description Entries
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004281 Docosahexaenoic Acids C22-unsaturated fatty acids found predominantly in FISH OILS. Docosahexaenoate,Docosahexaenoic Acid,Docosahexenoic Acids,Docosahexaenoic Acid (All-Z Isomer),Docosahexaenoic Acid Dimer (All-Z Isomer),Docosahexaenoic Acid, 3,6,9,12,15,18-Isomer,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer),Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cerium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cesium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Potassium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer),Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer,Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer, Sodium Salt,Docosahexaenoic Acid, Sodium Salt,Acid, Docosahexaenoic,Acids, Docosahexaenoic,Acids, Docosahexenoic
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D015118 Eicosapentaenoic Acid Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families. 5,8,11,14,17-Eicosapentaenoic Acid,Icosapent,5,8,11,14,17-Icosapentaenoic Acid,Eicosapentanoic Acid,Timnodonic Acid,omega-3-Eicosapentaenoic Acid,Acid, Eicosapentanoic,omega 3 Eicosapentaenoic Acid
D015525 Fatty Acids, Omega-3 A group of unsaturated fatty acids occurring mainly in fish oils, with three double bonds at particular positions in the hydrocarbon chain. N-3 Fatty Acid,Omega-3 Fatty Acid,Omega-3 Fatty Acids,n-3 Fatty Acids,n-3 Oil,n3 Oil,Omega 3 Fatty Acids,n-3 Oils,n-3 PUFA,n-3 Polyunsaturated Fatty Acid,n3 Fatty Acid,n3 Oils,n3 PUFA,n3 Polyunsaturated Fatty Acid,Acid, N-3 Fatty,Acid, Omega-3 Fatty,Fatty Acid, N-3,Fatty Acid, Omega-3,Fatty Acid, n3,N 3 Fatty Acid,Oil, n-3,Oil, n3,Omega 3 Fatty Acid,PUFA, n-3,PUFA, n3,n 3 Fatty Acids,n 3 Oil,n 3 Oils,n 3 PUFA,n 3 Polyunsaturated Fatty Acid

Related Publications

Daisuke Nishi, and Kuan-Pin Su, and Kentaro Usuda, and Jane Pei-Chen Chang, and Kei Hamazaki, and Tamaki Ishima, and Yo Sano, and Hiroe Ito, and Keiich Isaka, and Yoshiyuki Tachibana, and Shinji Tanigaki, and Tomo Suzuki, and Kenji Hashimoto, and Yutaka J Matsuoka
Women and omega-3 Fatty acids.
October 2004, Obstetrical & gynecological survey,
Daisuke Nishi, and Kuan-Pin Su, and Kentaro Usuda, and Jane Pei-Chen Chang, and Kei Hamazaki, and Tamaki Ishima, and Yo Sano, and Hiroe Ito, and Keiich Isaka, and Yoshiyuki Tachibana, and Shinji Tanigaki, and Tomo Suzuki, and Kenji Hashimoto, and Yutaka J Matsuoka
Comparative effects of omega-3 fatty acids in men and women.
May 1989, Clinical pharmacy,
Daisuke Nishi, and Kuan-Pin Su, and Kentaro Usuda, and Jane Pei-Chen Chang, and Kei Hamazaki, and Tamaki Ishima, and Yo Sano, and Hiroe Ito, and Keiich Isaka, and Yoshiyuki Tachibana, and Shinji Tanigaki, and Tomo Suzuki, and Kenji Hashimoto, and Yutaka J Matsuoka
[Effects of dietary omega-6 and omega-3 fatty acids on levels of long chain polyunsaturated fatty acids in erythrocytes].
January 1991, Comptes rendus des seances de la Societe de biologie et de ses filiales,
Daisuke Nishi, and Kuan-Pin Su, and Kentaro Usuda, and Jane Pei-Chen Chang, and Kei Hamazaki, and Tamaki Ishima, and Yo Sano, and Hiroe Ito, and Keiich Isaka, and Yoshiyuki Tachibana, and Shinji Tanigaki, and Tomo Suzuki, and Kenji Hashimoto, and Yutaka J Matsuoka
Dietary omega-3 fatty acids for women.
January 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Daisuke Nishi, and Kuan-Pin Su, and Kentaro Usuda, and Jane Pei-Chen Chang, and Kei Hamazaki, and Tamaki Ishima, and Yo Sano, and Hiroe Ito, and Keiich Isaka, and Yoshiyuki Tachibana, and Shinji Tanigaki, and Tomo Suzuki, and Kenji Hashimoto, and Yutaka J Matsuoka
Associations between plasma levels of omega-3 fatty acids and subsequent allergic diseases.
April 2021, Clinical nutrition ESPEN,
Daisuke Nishi, and Kuan-Pin Su, and Kentaro Usuda, and Jane Pei-Chen Chang, and Kei Hamazaki, and Tamaki Ishima, and Yo Sano, and Hiroe Ito, and Keiich Isaka, and Yoshiyuki Tachibana, and Shinji Tanigaki, and Tomo Suzuki, and Kenji Hashimoto, and Yutaka J Matsuoka
Omega-3 fatty acids and cognitive function in women.
January 2010, Women's health (London, England),
Daisuke Nishi, and Kuan-Pin Su, and Kentaro Usuda, and Jane Pei-Chen Chang, and Kei Hamazaki, and Tamaki Ishima, and Yo Sano, and Hiroe Ito, and Keiich Isaka, and Yoshiyuki Tachibana, and Shinji Tanigaki, and Tomo Suzuki, and Kenji Hashimoto, and Yutaka J Matsuoka
Antidepressant-like effects of omega-3 fatty acids in postpartum model of depression in rats.
September 2014, Behavioural brain research,
Daisuke Nishi, and Kuan-Pin Su, and Kentaro Usuda, and Jane Pei-Chen Chang, and Kei Hamazaki, and Tamaki Ishima, and Yo Sano, and Hiroe Ito, and Keiich Isaka, and Yoshiyuki Tachibana, and Shinji Tanigaki, and Tomo Suzuki, and Kenji Hashimoto, and Yutaka J Matsuoka
Cardiovascular effects of omega 3 fatty acids. Atherosclerosis risk factor modification by omega 3 fatty acids.
January 1991, World review of nutrition and dietetics,
Daisuke Nishi, and Kuan-Pin Su, and Kentaro Usuda, and Jane Pei-Chen Chang, and Kei Hamazaki, and Tamaki Ishima, and Yo Sano, and Hiroe Ito, and Keiich Isaka, and Yoshiyuki Tachibana, and Shinji Tanigaki, and Tomo Suzuki, and Kenji Hashimoto, and Yutaka J Matsuoka
Antiarrhythmic effects of omega-3 fatty acids.
August 2006, The American journal of cardiology,
Daisuke Nishi, and Kuan-Pin Su, and Kentaro Usuda, and Jane Pei-Chen Chang, and Kei Hamazaki, and Tamaki Ishima, and Yo Sano, and Hiroe Ito, and Keiich Isaka, and Yoshiyuki Tachibana, and Shinji Tanigaki, and Tomo Suzuki, and Kenji Hashimoto, and Yutaka J Matsuoka
Pleiotropic effects of omega-3 fatty acids.
January 2012, Recent patents on endocrine, metabolic & immune drug discovery,
Copied contents to your clipboard!